Immune-related adverse reactions are unique and quite different to adverse reactions of traditional chemotherapy, often with a delayed onset and can be of prolonged duration.

In this podcast, Doctor Damien Kee from Austin Health speaks to Associate Professor Phil Parente, Director of Cancer Services at Eastern Health, talk through their experiences in the management of immune-related adverse reactions with checkpoint inhibitors and provide tips for other oncologists.

the limbic · Immune-related adverse reaction management as part of contemporary
The views expressed in this podcast are the views of the presenters alone and are not necessarily reflective of the views of the sponsor. Please refer to the appropriate approved product information before prescribing any treatment mentioned in this podcast. Opdivo (nivolumab) Product Information can be found here. Please refer to www.pbs.gov.au for full PBS authority information.